Lucid Diligence Brief: Quotient and MSD ink a $2.2 billion IBD drug discovery deal
Lucid Diligence Brief: Quotient and MSD ink a $2.2 billion IBD drug discovery…
Lucid Diligence Brief: Fauna Bio obesity target designation with Lilly
Lucid Diligence Brief: Fauna Bio obesity target designation with Lilly…
Lucid Diligence Brief: Kupando adds €10 million to its Series A for Toll-like receptor assets
Lucid Diligence Brief: Kupando adds €10 million to its Series A for Toll-like…
Lucid Diligence Brief: PRISM BioLab × Receptor.AI collaboration
Lucid Diligence Brief: PRISM BioLab × Receptor.AI collaboration Professional…
Lucid Diligence Brief: Enodia Therapeutics Kezar Sec61 deal
Lucid Diligence Brief: Enodia Therapeutics Kezar Sec61 deal Professional…
Lucid Diligence Brief: kyron.bio x Servier strategic partnership
Lucid Diligence Brief: kyron.bio x Servier strategic partnership Professional…
Lucid Diligence Brief: Tenaya Therapeutics and Alnylam Cardiovascular Collaboration
Lucid Diligence Brief: Tenaya Therapeutics and Alnylam Cardiovascular…
Lucid Diligence Brief: Moonwalk Biosciences pivots from CRISPR-based epigenetic editing to siRNA obesity therapies
Lucid Diligence Brief: Moonwalk Biosciences pivots from CRISPR-based epigenetic…
Oncology Weekly News - September 22nd 2025
Oncology Update: RGT-61159 Orphan Drug, CRB-701 Fast Track, PDS0101 Survival…
Immunology Weekly News - September 17th 2025
🔬 This week in Immunology Updates: Immunology Licensing Deal, Phase II SKYWAY…
Rare Diseases Weekly News - September 11th 2025
🧬 This Week in Rare Diseases: Servier Fragile X deal, FDA RDEP, Bylvay Canada…
Neuroscience Weekly News - August 20th 2025
🧠This Week in Neuroscience: Apertura Gene Therapy, Boston AI Tool,…